The reduction in SF1 neuronal activity observed in this transgenic mouse did not compromise CRR to hypoglycemia, in contrast to previous studies in which chemogenic or optogenetic silencing of these neurons impaired recovery from hypoglycemia [32,76]. The gene discussed is SF1; the disease is Hypoglycemia.